The Patent Finder

Terms ending in 2032

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,045,417Isotopologues of Isoindole Derivatives
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,642,836Isotopologues of Isoindole Derivatives
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,637,500Aminopyridine and Carboxypyridine Compounds as Phosphodiesterase 10 Inhibitors
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,517,264Human FGF Receptor and Beta-Klotho Binding Proteins
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,853,175Phenethylsulfone Isoindoline Derivatives and Their Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,296,698Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,962,859Spiro-Amino-Imidazo-Fused Heterocyclic Compounds as Beta-Secretase Modulators and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,803,019Carrier Immunoglobulins and Uses Thereof
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 9,133,272Bispecific Binding Agents
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,134,652Human CGRP Receptor Binding Proteins
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
77 more term ends in 2032 · Pro
10 of 87 patents shown. Soonest term end first, then patent number.
Pro members see all 87.
Upgrade to Pro
85 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited